Top Health care stocks:
Health care shares were steady ahead of the bell on Monday.
- Dermira ( DERM ): halted as two phase 3 trials in acne vulgaris fail to meet co-primary endpoints
- Zynerba Pharmaceuticals ( ZYNE ): to launch pivotal study to support NDA for genetic disease drug
- Aimmune ( AIMT ): says phase 3 trial of AR101 in peanut allergy meets primary, secondary endpoints
- Boston Scientific ( BSX ): acquires medical device manufacturer EMcision
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.